Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
The Lancet. Global Health|September 16, 2022
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trialDeborah Watson-Jones, John Changalucha, Hilary Whitworth, et al.
The Lancet. Global Health|March 15, 2021
Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trialRanjeeta Thomas, William J M Probert, Rafael Sauter, et al.
Plos Medicine|March 2, 2011
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysisNicola Low, Matthew F Chersich, Kurt Schmidlin, et al.
Vaccine|June 30, 2026
Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girlsHilary S Whitworth, Khalid B Beshir, Kathy J Baisley, et al.
The Lancet. Global Health|January 31, 2025
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trialDeborah Watson-Jones, John Changalucha, Caroline Maxwell, et al.
Frontiers in Immunology|March 19, 2021
Cervicovaginal Immune Activation in Zambian Women With Female Genital SchistosomiasisAmy S Sturt, Emily L Webb, Catriona Patterson, et al.
Plos Medicine|January 23, 2015
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisCharles S Morrison, Pai-Lien Chen, Cynthia Kwok, et al.
The New England Journal of Medicine|July 18, 2019
Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART)Richard J Hayes, Deborah Donnell, Sian Floyd, et al.
Pageof 15